Archive: 05/03/2015
In vivo CRISPR-Cas9 screen sheds light on cancer metastasis and tumor evolution
For the first time, CRISPR-Cas9 gene-editing technology has been employed in a whole organism model to systematically target every gene in the genome. A team of scientists at the Broad Institute and MIT's David H. Koch Institute ...
Mar 5, 2015
Estimated costs of endocrine-disrupting chemical exposure exceed $209 billion annually
A new economic analysis found exposure to endocrine-disrupting chemicals likely costs the European Union €157 billion ($209 billion) a year in actual health care expenses and lost earning potential, according to a new series ...
Mar 5, 2015
Botox to improve smiles in children with facial paralysis
Injecting botulinum toxin A (known commercially as Botox) appears to be a safe procedure to improve smiles by restoring lip symmetry in children with facial paralysis, a condition they can be born with or acquire because ...
Mar 5, 2015
AbbVie shares sink after $21 bn deal for Pharmacyclics
AbbVie shares sank Thursday after the US pharmaceutical firm announced it will buy leukemia drug maker Pharmacyclics in a $21 billion deal.
Mar 5, 2015